Presentation is loading. Please wait.

Presentation is loading. Please wait.

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

Published byAxel Gustafsson Modified over 5 years ago

Similar presentations

Presentation on theme: "W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P"— Presentation transcript:

1 St Jude Medical Epic porcine bioprosthesis: Results of the regulatory evaluation 
W. R. Eric Jamieson, MD, Clifton T.P. Lewis, MD, Marc P. Sakwa, MD, Denton A. Cooley, MD, Vibhu R. Kshettry, MD, Kent W. Jones, MD, Tirone E. David, MD, John A. Sullivan, MD, Guy J. Fradet, MD, David S. Bach, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 141, Issue 6, Pages e2 (June 2011) DOI: /j.jtcvs Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Freedom from reoperation owing to SVD for AVR by age groups (≤60, 61–70, >70 years). SVD, Structural valve deterioration; AVR, aortic valve replacement. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Freedom from reoperation owing to SVD for MVR by age groups (≤60, 61–70, >70 years). SVD, Structural valve deterioration; MVR, mitral valve replacement. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

4 Patient survival AVR by age groups (≤60, 61–70, >70 years)
Patient survival AVR by age groups (≤60, 61–70, >70 years). AVR, Aortic valve replacement; SE, standard error. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

5 Patient survival MVR by age groups (≤60, 61–70, >70 years)
Patient survival MVR by age groups (≤60, 61–70, >70 years). MVR, Mitral valve replacement; SE, standard error. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

6 Hemodynamics—aortic valve replacement (mean gradients and effective orifice areas) at 6 months and 2 years. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

7 Hemodynamics—mitral valve replacement (mean gradients and effective orifice areas) at 6 months and 2 years. The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

8 Left ventricular (LV) mass regression.
The Journal of Thoracic and Cardiovascular Surgery  , e2DOI: ( /j.jtcvs ) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P"

Similar presentations

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P

W. R. Eric Jamieson, MD, Clifton T. P. Lewis, MD, Marc P
Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Of mice and men and surgical transcatheter aortic valve insertion

Of mice and men and surgical transcatheter aortic valve insertion
Twenty-Five Year Experience With the St

Twenty-Five Year Experience With the St
The fate of small-size pericardial heart valve prostheses in an older patient population  Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,

The fate of small-size pericardial heart valve prostheses in an older patient population  Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,
Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,
Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: A prospective multicenter study  Vincent Chan,

Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: A prospective multicenter study  Vincent Chan,
Endoscopic Robotic Mitral Valve Surgery

Endoscopic Robotic Mitral Valve Surgery
Fate of aortic bioprostheses: An 18-year experience

Fate of aortic bioprostheses: An 18-year experience
Usefulness of microsimulation to translate valve performance into patient outcome: Patient prognosis after aortic valve replacement with the Carpentier–Edwards.

Usefulness of microsimulation to translate valve performance into patient outcome: Patient prognosis after aortic valve replacement with the Carpentier–Edwards.
Prospective randomized comparison of CarboMedics and St

Prospective randomized comparison of CarboMedics and St
Bigger valve size is not always better

Bigger valve size is not always better
When is the Ross operation a good option to treat aortic valve disease?  Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc 

When is the Ross operation a good option to treat aortic valve disease?  Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc 
George J. Reul, M. D. , Denton A. Cooley, M. D. , J. Michael Duncan, M

George J. Reul, M. D. , Denton A. Cooley, M. D. , J. Michael Duncan, M
Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age  Torsten Christ,

Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age  Torsten Christ,
W. R. Eric Jamieson, MD, Guy J. Fradet, MD, James G

W. R. Eric Jamieson, MD, Guy J. Fradet, MD, James G
The fate of small-size pericardial heart valve prostheses in an older patient population  Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,

The fate of small-size pericardial heart valve prostheses in an older patient population  Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario,
Reoperative “valve-in-valve” transapical transcatheter mitral valve replacement in a high-risk patient with a recent transapical transcatheter aortic.

Reoperative “valve-in-valve” transapical transcatheter mitral valve replacement in a high-risk patient with a recent transapical transcatheter aortic.
Long-Term Outcomes of the Mosaic Bioprosthesis

Long-Term Outcomes of the Mosaic Bioprosthesis

Similar presentations

Ads by Google